160 related articles for article (PubMed ID: 28548282)
21. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis.
Borst SE; Shuster JJ; Zou B; Ye F; Jia H; Wokhlu A; Yarrow JF
BMC Med; 2014 Nov; 12():211. PubMed ID: 25428524
[TBL] [Abstract][Full Text] [Related]
22. Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation.
Sharma R; Oni OA; Gupta K; Sharma M; Sharma R; Singh V; Parashara D; Kamalakar S; Dawn B; Chen G; Ambrose JA; Barua RS
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28487389
[TBL] [Abstract][Full Text] [Related]
23. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
24. Testosterone Replacement Therapy and Mortality in Older Men.
Hackett GI
Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
[TBL] [Abstract][Full Text] [Related]
25. Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies.
Liu J; Weinhandl ED; Gilbertson DT; Collins AJ; St Peter WL
Kidney Int; 2012 Feb; 81(4):341-50. PubMed ID: 22089946
[TBL] [Abstract][Full Text] [Related]
26. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
27. Immortal time bias for life-long conditions in retrospective observational studies using electronic health records.
Tyrer F; Bhaskaran K; Rutherford MJ
BMC Med Res Methodol; 2022 Mar; 22(1):86. PubMed ID: 35350993
[TBL] [Abstract][Full Text] [Related]
28. Retrospective Analysis of Dose Titration and Serum Testosterone Level Assessments in Patients Treated With Topical Testosterone.
Muram D; Kaltenboeck A; Boytsov N; Hayes-Larson E; Ivanova J; Birnbaum HG; Swindle R
Am J Mens Health; 2015 Nov; 9(6):496-505. PubMed ID: 25271142
[TBL] [Abstract][Full Text] [Related]
29. Testosterone treatment and mortality in men with low testosterone levels.
Shores MM; Smith NL; Forsberg CW; Anawalt BD; Matsumoto AM
J Clin Endocrinol Metab; 2012 Jun; 97(6):2050-8. PubMed ID: 22496507
[TBL] [Abstract][Full Text] [Related]
30. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
Anderson JL; May HT; Lappé DL; Bair T; Le V; Carlquist JF; Muhlestein JB
Am J Cardiol; 2016 Mar; 117(5):794-9. PubMed ID: 26772440
[TBL] [Abstract][Full Text] [Related]
31. Quantifying the impact of survivor treatment bias in observational studies.
Austin PC; Mamdani MM; van Walraven C; Tu JV
J Eval Clin Pract; 2006 Dec; 12(6):601-12. PubMed ID: 17100859
[TBL] [Abstract][Full Text] [Related]
32. Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis.
Boyle P; Koechlin A; Bota M; d'Onofrio A; Zaridze DG; Perrin P; Fitzpatrick J; Burnett AL; Boniol M
BJU Int; 2016 Nov; 118(5):731-741. PubMed ID: 26779889
[TBL] [Abstract][Full Text] [Related]
33. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
34. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
[TBL] [Abstract][Full Text] [Related]
35. Testosterone Replacement Therapy and Components of the Metabolic Syndrome.
Anaissie J; Roberts NH; Wang P; Yafi FA
Sex Med Rev; 2017 Apr; 5(2):200-210. PubMed ID: 28202344
[TBL] [Abstract][Full Text] [Related]
36. Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam.
; Le TG; Ngo L; Mehta S; Do VD; Thach TQ; Vu XD; Nguyen DT; Cohen A
Res Rep Health Eff Inst; 2012 Jun; (169):5-72; discussion 73-83. PubMed ID: 22849236
[TBL] [Abstract][Full Text] [Related]
37. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
38. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
[TBL] [Abstract][Full Text] [Related]
39. Immortal time bias in observational studies of time-to-event outcomes.
Jones M; Fowler R
J Crit Care; 2016 Dec; 36():195-199. PubMed ID: 27546771
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
